Related Image: Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness |
(Date:11/9/2009)... may be left atrial enlargement, study finds , ...y is a major risk factor for left atrial enlargeme...n, stroke and death, a new study shows. , Atria...ia (an irregular heart rhythm or heartbeat). ,... aged 25 to 74, in Germany who were followed for 1...
(Date:11/9/2009)...ikely due to fact that both eye conditions are age...v. 9 (HealthDay News) -- Cataract surgery doesn,t ...ular degeneration (AMD), according to a new study ... of vision loss worsens the other. , "Because b...viduals with cataract also have AMD," wrote Li Min...
(Date:11/9/2009)...y of care increases with longer doctor visits, res...ay News) -- Family doctors are now taking more tim... often and improving the quality of visits, a new ...h their primary care physicians during office visi...and overall they seemed to receive better care," s...
(Date:11/9/2009)... Course, to be Offered in April...oolkit , Cambridge, MA (V...hysicians for Human Rights (PHR) first inspected a...stan , he realized he would need a team of experts...ting the site properly was a key first step in sec...
(Date:11/9/2009)...LEBANON, Tenn., Nov. 9 Health Conn...ounced it will host their inaugural Hospital O.R. ...10 at the Marriott Renaissance Hotel in Nashville,...more than 100 hospital operating room directors an...health systems in the country. Some of the confirm...
Breaking Medicine News(10 mins):Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Doctors Spending More Time Now With Patients 2Health News:Doctors Spending More Time Now With Patients 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2...tes its 50th anniversary this holiday season, MIN...t,Minneapolis-based Courage Center, announces its ...ard collection. This season, Courage Cards is,cele...Rapids, Wis. -- Nature,s Peace, an,original waterc...
...fit the Cancer Center at Children,s Hospital of ...PHIA, Sept. 8 aloft(SM) hotels, Starwood Hotels,a...festyle brand, which,opened in Philadelphia on 8.8..., A Philadelphia suburb and Havertown native, Han...
... Terrell Samuels, CEO of The,Marketing Doctor LLC,...r,exclusive roster ... fertility specialist Dr. Pe...ls. Dr. Saadat is a well-respected fertility,speci...es, internet, radio, television networks, reality ...
...ildren wielding club while playing away from cours...ay News) -- Although rare, golf-related eye injure...y. , The researchers looked at six boys and five ...ercent) by a golf ball," wrote Dr. Eric M. Hink, o...
...e brain shrinkage, study shows , , MONDAY,...h low levels of vitamin B12 seem to be at increase...esearch suggests. , Brain atrophy is associated wi...levels of B12 actually cause brain atrophy, they...
...The U.S. Department of,Veterans Affairs (VA) annou...g veterans, voter registration activities, with pa...ommunity living centers, domiciliaries and,patient...ups to its hospitals and outpatient clinics to ass...
Other Medicine News:Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 2Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 3Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 4Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 5Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 6Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 7Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 8Health News:aloft(SM) hotels Congratulates Hometown Olympic Swimmer and Gold Medalist Brendan Hansen Friday, September 12, 2008 2Health News:Kids' Eye Injuries From Golf Clubs Rare But Severe 2Health News:Vitamin B12 Key to Aging Brain 2Health News:Vitamin B12 Key to Aging Brain 3Health News:VA Clarifies Voter Registration Regulations 2(Date:11/9/2009)...v. 9 /PRNewswire-Asia-FirstCall/ -- American Orien...any" or "AOBO"), a pharmaceutical,company dedicate...ufacture and,commercialization of a broad range of...s, today announced that it plans to release third ... 16, 2009, after the market closes. , The...
(Date:11/9/2009)...N.J., Nov. 9 Par Pharmac...ced that it has extended the expiration date and i...unced "Modified Dutch Auction" tender offer, in wh...65,000,000 aggregate principal amount, or up to ap...r Subordinated Convertible Notes due 2010. ,, T...
(Date:11/9/2009)...9, 2009 Arena Pharmaceut...ial results for the third quarter ended September ...locable to common stockholders in the third quarte...mpared to a net loss allocable to common stockhold... or $0.76 per share, and a net loss allocable to c...
Breaking Medicine Technology:Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Customers Design Reid Supply 26apos 3Bs New Web Site 50846 1Customers Design Reid Supply 26apos 3Bs New Web Site 50846 2Customers Design Reid Supply 26apos 3Bs New Web Site 50846 3Customers Design Reid Supply 26apos 3Bs New Web Site 50846 4Customers Design Reid Supply 26apos 3Bs New Web Site 50846 5MRI accurately depicts deep endometriosis 50842 1MRI accurately depicts deep endometriosis 50842 2SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 1SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 2SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 3...t and Phase 1b Combination Clinical Trials ...y, SOUTH SAN FRANCISCO, Calif., June 16 Sunesis,...ata Saturday from two,clinical trials of the compa...595), including updated results of a Phase 1 trial...sed or refractory patients with acute,myeloid leuk...
...Pharmaceuticals,Inc. (Amex: ANX ) today provided ... Phase 2b clinical trial of CoFactor for the treat...verall survival results in this,study have been re...fluorouracil) arm demonstrating a 14 day improveme...5-FU arm., "In the Phase 2b study, CoFactor was d...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 6ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 2ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 3Utility & Splinter Forceps #H
Evisceration Disposible Sizers
Straight Iris Forceps
Semkin Forceps with stops
Medicine Products: